ARTERIAL VASCULAR ENGINEERING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARTERIAL VASCULAR ENGINEERING

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: B4TheBell who wrote (323)	12/30/1997 3:18:00 PM
From: D.E. Shetland	of 339

I see a UK company (Biocompatibles) just got CE Mark Approval to sell stents in Europe and that the re-stenosis rate exhibited in the trials was around 5%. I believe the design and a coating applied to it account for the high success rate. That's quite a bit below the other stent's on the market. Anyone have an idea what such a low number might do to market share's in Europe & (I guess) eventually, US?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next